Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$87.54 -0.42 (-0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Share-based Compensation (2019 - 2026)

Updated

Mirum Pharmaceuticals (MIRM) reported Share-based Compensation of $30.57 million for Q2 2026, up 65.5% from $18.47 million a year earlier but down 15.5% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Share-based Compensation (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Mirum Pharmaceuticals' Share-based Compensation came in at $103.93 million, up 74.9% year-over-year; for FY2025, it came in at $71.42 million, up 47.4% from FY2024.

  • Share-based Compensation has increased for six consecutive years, with a five-year compound annual growth rate of 41.6% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $48.44 million in FY2024 (+38.3%), $35.02 million in FY2023 (+29.7%), $27.01 million in FY2022 (+17.0%) and $23.09 million in FY2021 (+83.9%).
  • Five-year quarterly Share-based Compensation spans a low of $5.56 million in Q4 2021 and a high of $36.2 million in Q1 2026.
  • Year over year, Share-based Compensation has now increased in each of the last 15 quarters, with growth averaging 57.9% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q1 2026 (growth of 129.1%); the low point was Q3 2022 (a decline of 9.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $36.2 million (Q1 2026), $19.03 million (Q4 2025) and $18.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Mirum Pharmaceuticals 5.70 Bn 4.11 Bn 145.90 Mn 30.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.57 Mn
Mar 31, 2026 36.20 Mn
Dec 31, 2025 19.03 Mn
Sep 30, 2025 18.13 Mn
Jun 30, 2025 18.47 Mn
Mar 31, 2025 15.80 Mn
Dec 31, 2024 13.25 Mn
Sep 30, 2024 11.91 Mn
Jun 30, 2024 11.84 Mn
Mar 31, 2024 11.45 Mn
Dec 31, 2023 9.72 Mn
Sep 30, 2023 8.39 Mn
Jun 30, 2023 8.36 Mn
Mar 31, 2023 8.56 Mn
Dec 31, 2022 6.90 Mn
Sep 30, 2022 6.73 Mn
Jun 30, 2022 6.82 Mn
Mar 31, 2022 6.56 Mn
Dec 31, 2021 5.56 Mn
Sep 30, 2021 7.42 Mn
API Access

Mirum Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MIRM&period=max&api_key=YOUR_API_KEY